Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
The business and product range of Ipca and that of Unichem complements each others business and product range
The acquisition is a crucial step in LTS' strategy to broaden its portfolio of drug delivery platforms.
The acquisition would be by way of a share purchase agreement dated Dec. 26, 2022.
Everest and SPH Kyuan will work closely to promote import and channel distribution of XERAVA in China
Enabling wireless monitoring In ambulances and homes
Azithromycin Tablets USP, 500 mg had annual sales of US $20 million in the United States
Apremilast Tablets, 10 mg, 20 mg, and 30 mg is a generic equivalent of reference listed drug (RLD) OTEZLA of Celgene.
Subscribe To Our Newsletter & Stay Updated
